Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency

Neurol Neuroimmunol Neuroinflamm. 2019 Oct 9;6(6):e628. doi: 10.1212/NXI.0000000000000628. Print 2019 Nov.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Humans
  • Immunologic Factors / pharmacology*
  • Leukoencephalopathy, Progressive Multifocal / drug therapy*
  • Leukoencephalopathy, Progressive Multifocal / etiology*
  • Male
  • Primary Immunodeficiency Diseases / complications*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • pembrolizumab